Corona Remedies IPO

Corona Remedies IPO Allotment Update: GMP Hints at Strong 28% Listing Jump

The Corona Remedies IPO has become one of the most talked‑about public offerings on the Indian markets this December. Investors are watching closely. We from the investing community have seen strong demand, huge subscription numbers, and a rising Grey Market Premium (GMP). These trends point to a likely good debut on the listing day. Who…

Sanofi

Sanofi Gains Approval for Bleeding-Disorder Treatments in China

Sanofi has achieved a major milestone by securing approval for two innovative bleeding‑disorder treatments in China, as announced recently by the company and local regulators. The Chinese National Medical Products Administration (NMPA) granted approvals for Qfitlia and Cablivi, two specialized medicines designed to treat rare and serious blood disorders, strengthening Sanofi’s presence in one of…

Byju Raveendran
|

Byju Raveendran Secures Victory After US Court Scraps $1 Billion Penalty

In a major legal breakthrough for Byju Raveendran, the US Bankruptcy Court in Delaware has reversed its previous ruling that had ordered him to pay over USD 1 billion in damages. This decision brings significant relief to the embattled founder of Byju’s, one of India’s most well-known edtech companies, after a long and complex cross-border…